Constituents of Morning Glory as Anticancer Agents

Description:

Ipomoeassin compounds derived from morning glory plant material (especially Ipomoea sp. from Suriname) are useful as anti-cancer agents. The novel compounds also are useful for treating neurodegenerative disorders (such as Alzheimer's disease) in human patients.

Patent Information:

Title	App Type	Country	Serial No.	Patent No.	File Date	Issued Date	Expire Date	Patent Status
Morning Glory-Derived Anticancer Agents, and Novel Ipomoeassin Compounds	US Utility	*United States	11/366,806	7,560,536	3/3/2006	7/14/2009	8/15/2026	Issued

Direct Link:

http://vtip.technologypublisher.com/technology/10247

Category(s):

Biomedical

Bookmark this page

Download as PDF

For Information, Contact:

Mike Miller

Senior Licensing Manager

Virginia Tech Intellectual Properties, Inc.

(540) 443-9228

mmiller@vtip.org

Inventors:

David Kingston

Shugeng Cao